Archive: Biotech Stocks

biotech

3 Small Biotech Moonshots To Add To Your Portfolio

As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio.  Sentiment on the biotech sector early in 2017 sure has […]

biotechnology

3 Biotech Stock Beneficiaries Of A Streamlined FDA

With lower approval wait times and decreased regulations on the horizon, long-term investing opportunities in the biotech sector haven’t looked this great in over two years. Take a look at these three stocks in particular as they will reap the most reward from a streamlined FDA.  After an approximate gain of 10% in February, the […]

phamaceuticals

3 Attractive Growth Stocks With Near-Term Catalysts

The market is off to a much stronger start this year than the bloodbath equities were greeted with to begin 2016. Biotech, after a dismal 18 months of underperformance is no exception. Sentiment on this beaten down part of the market started to improve immediately after the unexpected election result in November. The specter of […]

biotech

The 3 Golden Rules Of Successful Biotech Investing

If you want to invest successfully in one of the few sectors where 1,000% gains are anything but unusual, follow these three “golden rules” that Bret Jensen has developed over his decades-long career. The 45th President of the United States will be inaugurated this week and the stock market has started out 2017 on much […]

biotechnology

3 Stocks Under $10 With Breakout Potential

After executing perfectly on their business plans in 2016, these three stocks look set to reap the profits in 2017. With buyout potential and higher share prices expected in the New Year, adding these three stocks to your portfolio today looks like a smart move.  It is hard to believe 2016 has already come and […]

phamaceuticals

3 Biotech Stocks Set To Soar Under Republican Leadership

After being the market’s whipping boy for the last year, the biotech sector looks ready to rebound under a pro-business White House. Already, many stocks have shot up over 50%, but Bret Jensen shares three today that still have plenty of upside backed up by strong products already on the market.  The biotech sector has […]

Follow The Money: 8 Stocks With Heavy Insider Buying

Follow The Money: 8 Stocks With Heavy Insider Buying

Who knows a stock’s growth prospects better than an executive? Chances are not many people, so that’s why Bret Jensen is profiling eight companies seeing huge insider buying over the last couple of months. Such large purchases signal insider confidence that can lead to huge share price gains.  The unexpected Trump election victory is still […]

biotechnology

4 Top Biotech Stocks To Be Purchased On The Cheap

Biotech stocks took a tumble last week, but for the long-term investor these valuations are a gift. Snap up shares of these four promising stocks for a discount today and take advantage of these too-low prices. Last week was brutal for biotech investors. The main indices dropped more than six percent just in Tuesday’s and […]

phamaceuticals

4 Takeover Targets In The Market’s Hottest Sector

There has been a fast and furious resurgence in M&A in this sector with tens of billions of dollars of deals going down in just the last couple of months. With expectations that dealmaking will continue to increase, consider these four stocks as solid investments with the chance for huge returns if they are purchased […]

biotech

4 Must-Own Biotech Stocks As The Sector Comes Charging Back

Up 20% over the last three months, the biotech sector has come roaring back with a vengeance. Given the positive outlook for this sector, Bret Jensen shares his four “must-own” picks through year-end. After three quarters of significantly underperforming the overall market, the biotech sector has roared back in a big way so far in […]

biotech

The Next 3 Major Biotech Takeover Targets

After record years for deal volume in both 2014 and 2015 in the biotech and pharma industries, M&A transactions have posted a significant decline in the volume of deals so far in 2016 across these industries. As of late August, transactions based on dollar volume were down almost 65% from the same period in 2015. […]